Institutional Ownership Verona Pharma PLC (VRNA)
This table provides information about the institutional ownership of Verona Pharma PLC (VRNA). We have compiled data on the 305 institutions that hold shares in the stock, with a total of 73.5 Million shares, which have been reported (via 13F filing form) to have a value of $7.73 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Janus Henderson Group PLC
London, X0 |
Aug 14, 2025 Q2 2025 |
6,134,405
shares
|
$645 Million
0.3% of portfolio
|
Q2 2025
Added 11.19%
|
|
Perceptive Advisors LLC
New York, NY |
Aug 14, 2025 Q2 2025 |
5,507,591
shares
|
$579 Million
22.87% of portfolio
|
Q2 2025
Reduced 16.09%
|
|
Darwin Global Management, Ltd.
St. Helier, Y9 |
May 15, 2025 Q1 2025 |
3,923,204
shares
|
$413 Million
17.31% of portfolio
|
Q1 2025
Added 384.08%
|
|
Frazier Life Sciences Management, L.P.
Menlo Park, CA |
Aug 14, 2025 Q2 2025 |
3,383,950
shares
|
$356 Million
16.88% of portfolio
|
Q2 2025
Reduced 2.14%
|
|
Rtw Investments, LP
New York, NY |
Aug 14, 2025 Q2 2025 |
3,051,878
shares
|
$321 Million
4.43% of portfolio
|
Q2 2025
Added 7.13%
|
|
Eventide Asset Management, LLC
Boston, MA |
Aug 14, 2025 Q2 2025 |
2,715,324
shares
|
$286 Million
4.88% of portfolio
|
Q2 2025
Reduced 6.16%
|
|
Goldman Sachs Group Inc
New York, NY |
Aug 14, 2025 Q2 2025 |
2,617,297
shares
|
$275 Million
0.04% of portfolio
|
Q2 2025
Added 151.32%
|
|
Abingworth LLP
London, X0 |
Feb 10, 2023 Q4 2022 |
2,457,500
shares
|
$259 Million
21.3% of portfolio
|
Q2 2022
Added 0.0%
|
|
Nea Management Company, LLC
Timonium, MD |
Aug 14, 2025 Q2 2025 |
2,263,138
shares
|
$238 Million
17.75% of portfolio
|
Q2 2025
Reduced 15.82%
|
|
Summit Partners Public Asset Management, LLC
Boston, MA |
Aug 14, 2025 Q2 2025 |
2,144,286
shares
|
$226 Million
6.35% of portfolio
|
Q2 2025
Reduced 7.7%
|
|
Farallon Capital Management LLC
San Francisco, CA |
Aug 14, 2025 Q2 2025 |
1,810,000
shares
|
$190 Million
0.77% of portfolio
|
Q2 2025
Added 66.82%
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Aug 14, 2025 Q2 2025 |
1,789,513
shares
|
$188 Million
0.02% of portfolio
|
Q2 2025
Reduced 4.11%
|
|
Lee Ainslie
Maverick Capital LTD | Dallas, Tx
|
May 15, 2025 Q1 2025 |
1,783,498
shares
|
$188 Million
2.23% of portfolio
|
Q1 2025
Reduced 42.99%
|
|
Wellington Management Group LLP
Boston, MA |
Aug 14, 2025 Q2 2025 |
1,629,848
shares
|
$171 Million
0.03% of portfolio
|
Q2 2025
Reduced 23.54%
|
|
Morgan Stanley
New York, NY |
May 15, 2025 Q1 2025 |
1,624,127
shares
|
$171 Million
0.01% of portfolio
|
Q1 2025
Added 9.46%
|
|
Hood River Capital Management LLC
Palm Beach Gardens, FL |
Aug 14, 2025 Q2 2025 |
1,562,467
shares
|
$164 Million
2.38% of portfolio
|
Q2 2025
Added 1.97%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Aug 14, 2025 Q2 2025 |
1,415,219
shares
|
$149 Million
0.11% of portfolio
|
Q2 2025
Added 130.49%
|
|
Vivo Capital, LLC
Palo Alto, CA |
Aug 13, 2025 Q2 2025 |
1,393,432
shares
|
$147 Million
27.9% of portfolio
|
Q2 2025
Reduced 3.15%
|
|
Holocene Advisors, LP
New York, NY |
May 15, 2025 Q1 2025 |
1,366,680
shares
|
$144 Million
0.27% of portfolio
|
Q1 2025
New holding
|
|
Ubs Group Ag
|
Aug 14, 2025 Q2 2025 |
1,186,181
shares
|
$125 Million
0.02% of portfolio
|
Q2 2025
Added 351.27%
|
|
Franklin Resources Inc
San Mateo, CA |
Aug 12, 2025 Q2 2025 |
1,159,662
shares
|
$122 Million
0.03% of portfolio
|
Q2 2025
Added 14.4%
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
Aug 13, 2025 Q2 2025 |
1,146,095
shares
|
$121 Million
0.22% of portfolio
|
Q2 2025
Reduced 9.6%
|
|
Foresite Capital Management Iii, LLC
Larkspur, CA |
Nov 14, 2022 Q3 2022 |
1,111,112
shares
|
$117 Million
29.98% of portfolio
|
Q1 2021
New holding
|
|
Stanley Druckenmiller
Duquesne Family Office LLC | New York, Ny
|
May 15, 2025 Q1 2025 |
1,002,080
shares
|
$105 Million
2.08% of portfolio
|
Q1 2025
Added 12.9%
|
|
Artia Global Partners LP
Miami, FL |
Aug 14, 2025 Q2 2025 |
924,204
shares
|
$97.2 Million
21.03% of portfolio
|
Q2 2025
Added 71.63%
|